Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2010 | PhaseBio Pharmaceuticals | $25.0M Series B | Justin Klein, OSI Investment Management | Bain Capital Life Sciences, Hatteras Venture Partners, Johnson & Johnson Innovation, Red Tree Venture Capital, Vensana Capital, James Barrett, Fletcher Spaght Ventures, Johnson & Johnson Innovation |